These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6089844)

  • 1. The conformation of apolipoprotein E isoforms in phospholipid complexes and their interaction with human Hep G2 cells.
    Cassel DL; Phillips MC; Rostron P; Rothblat GH; Utermann G
    Atherosclerosis; 1984 Aug; 52(2):203-18. PubMed ID: 6089844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of dissociation of human apolipoproteins A-I, A-11, and C from complexes with dimyristoylphosphatidylcholine as studied by thermal denaturation.
    Reijngoud DJ; Phillips MC
    Biochemistry; 1984 Feb; 23(4):726-34. PubMed ID: 20815113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of fatty acids on apolipoprotein B secretion by human hepatoma cells (HEP G2).
    Arrol S; Mackness MI; Durrington PN
    Atherosclerosis; 2000 Jun; 150(2):255-64. PubMed ID: 10856517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of N-4909 analogs. Part I. A stimulant of apolipoprotein E secretion in human hepatoma G2 cells.
    Yanai M; Suzuki M; Kawamura K; Oshida N; Hiramoto S; Yasuda O; Shingai A; Suguro T
    J Antibiot (Tokyo); 2000 Dec; 53(12):1385-96. PubMed ID: 11217804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Butyrate stimulates the secretion of apolipoprotein (apo) A-I and apo B100 by the human hepatoma cell line Hep G2. Induction of apo A-I mRNA with no change of apo B100 mRNA.
    Kaptein A; Roodenburg L; Princen HM
    Biochem J; 1991 Sep; 278 ( Pt 2)(Pt 2):557-64. PubMed ID: 1654887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of dissociation of human apolipoprotein A-I from complexes with dimyristoylphosphatidylcholine as studied by guanidine hydrochloride denaturation.
    Reijngoud DJ; Phillips MC
    Biochemistry; 1982 Jun; 21(12):2969-76. PubMed ID: 6809042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor-mediated endocytosis of tissue-type plasminogen activator by the human hepatoma cell line Hep G2.
    Owensby DA; Sobel BE; Schwartz AL
    J Biol Chem; 1988 Aug; 263(22):10587-94. PubMed ID: 2839497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normalization of receptor binding of apolipoprotein E2. Evidence for modulation of the binding site conformation.
    Innerarity TL; Weisgraber KH; Arnold KS; Rall SC; Mahley RW
    J Biol Chem; 1984 Jun; 259(11):7261-7. PubMed ID: 6327714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein synthesis and secretion in Hep G2 cells: effects of monensin and cycloheximide.
    Hahn SE; Parkes JG; Goldberg DM
    Biochem Cell Biol; 1992 Dec; 70(12):1339-46. PubMed ID: 1338570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects.
    Rall SC; Weisgraber KH; Innerarity TL; Mahley RW
    Proc Natl Acad Sci U S A; 1982 Aug; 79(15):4696-700. PubMed ID: 6289314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of the serum amyloid A proteins with phospholipid.
    Bausserman LL; Herbert PN; Forte T; Klausner RD; McAdam KP; Osborne JC; Rosseneu M
    J Biol Chem; 1983 Sep; 258(17):10681-8. PubMed ID: 6411718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular metabolism of human apolipoprotein(a) in stably transfected Hep G2 cells.
    Lobentanz EM; Krasznai K; Gruber A; Brunner C; Müller HJ; Sattler J; Kraft HG; Utermann G; Dieplinger H
    Biochemistry; 1998 Apr; 37(16):5417-25. PubMed ID: 9548923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 25-hydroxycholesterol and bile acids on the regulation of cholesterol metabolism in Hep G2 cells.
    Carlson TL; Kottke BA
    Biochem J; 1989 Nov; 264(1):241-7. PubMed ID: 2513806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype.
    Rall SC; Weisgraber KH; Innerarity TL; Bersot TP; Mahley RW; Blum CB
    J Clin Invest; 1983 Oct; 72(4):1288-97. PubMed ID: 6313758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of low-density lipoprotein receptors in the human hepatoma cell line Hep G2.
    Illingworth DD; Lindsey S; Hagemenas FC
    Exp Cell Res; 1984 Dec; 155(2):518-26. PubMed ID: 6094224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of lipoprotein production in Hep G2 cells by fenofibrate and clofibrate.
    Hahn SE; Goldberg DM
    Biochem Pharmacol; 1992 Feb; 43(3):625-33. PubMed ID: 1311585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-poor apolipoprotein A-I in Hep G2 cells: formation of lipid-rich particles by incubation with dimyristoylphosphatidylcholine.
    Forte TM; Nichols AV; Selmek-Halsey J; Caylor L; Shore VG
    Biochim Biophys Acta; 1987 Aug; 920(3):185-94. PubMed ID: 3038192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoprotein specificity in the hepatic uptake of apolipoprotein E and the pathogenesis of familial dysbetalipoproteinemia.
    Havel RJ; Chao Y; Windler EE; Kotite L; Guo LS
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4349-53. PubMed ID: 6933487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of insulin on synthesis and secretion of apolipoproteins A I, A II, B100, C III and E by cultured HepG2 cells].
    Wang H; Liu B
    Hua Xi Yi Ke Da Xue Xue Bao; 1999 Sep; 30(3):233-5. PubMed ID: 12212269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein binding to cultured human hepatoma cells.
    Krempler F; Kostner GM; Friedl W; Paulweber B; Bauer H; Sandhofer F
    J Clin Invest; 1987 Aug; 80(2):401-8. PubMed ID: 3038957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.